Share Pledge Creation
Ajanta Pharma Promoter Creates Fresh Pledge on 28.56 Lakh Shares for New Loan
NSE
ajantpharm
BSE
532331
Ajanta Pharma Limited has received a promoter disclosure regarding creation of a fresh pledge on 28,55,925 equity shares by Ayush Agrawal, trustee of Ayush Agrawal Trust. The pledge has been created in favour of CTL Trusteeship Limited for obtaining a new loan. Following the transaction, total pledged shares of the trust increased to 1.14 crore shares, representing 9.16% of the company’s equity capital.
PRICE-SENSITIVE TRIGGER
Event: Creation of promoter share pledge.
Type: Share Pledge Creation
Impact: Neutral
Immediate Effect: Promoter entity Ayush Agrawal Trust has pledged an additional 28.56 lakh shares for securing a new loan facility, increasing its total encumbered holding.
Key Metrics:
- Fresh Shares Pledged: 28,55,925 shares
- Percentage of Equity Capital Pledged: 2.29%
- Pledge Creation Date: June 2, 2026
- Pledgee: CTL Trusteeship Limited
- Reason: New Loan
- Total Promoter Holding (Ayush Agrawal Trust): 1,41,12,924 shares
- Promoter Holding Percentage: 11.30%
- Total Shares Pledged After Transaction: 1,14,45,087 shares
- Post-Pledge Share Capital Percentage: 9.16%
Highlight:
- Promoter trust created a fresh pledge of 28.56 lakh shares (2.29% equity) for securing a new loan facility.
What Happened ?
Ayush Agrawal, trustee of Ayush Agrawal Trust and part of the promoter group of Ajanta Pharma Limited, disclosed the creation of a pledge over 28,55,925 equity shares of the company.
The pledge was created on June 2, 2026 in favour of CTL Trusteeship Limited. The stated purpose of the encumbrance is to obtain a new loan.
Following this transaction, the trust’s total pledged shares increased from 85,89,162 shares to 1,14,45,087 shares.
Key Details
Promoter Pledge Transaction:
- Disclosure made under SEBI (SAST) Regulations, 2011.
- Encumbrance type: Creation of pledge.
- Promoter entity involved: Ayush Agrawal Trust.
- Trustee: Ayush Agrawal.
- Shares pledged: 28,55,925 equity shares.
- Pledge creation date: June 2, 2026.
- Purpose: New loan.
- Pledge holder: CTL Trusteeship Limited.
- Post-transaction pledged holding: 1,14,45,087 shares.
- Post-transaction pledged percentage of equity capital: 9.16%.
Note:
- The disclosure relates only to promoter financing arrangements and does not involve issuance of new shares, dilution of equity, or any change in company operations.
Risk Analysis
Summary:
- Promoter pledging is generally monitored by investors because higher encumbered holdings can increase financing-related risks if share prices decline significantly. However, the disclosure indicates the pledge was created for obtaining a new loan and does not directly affect the company’s business operations.
Key Risks:
- Increase in promoter encumbered shareholding.
- Pledged shares may be subject to lender enforcement under adverse circumstances.
- Higher promoter leverage can become a governance concern if pledge levels continue to rise.
- No operational or business impact has been disclosed.
Worst Case Scenario:
- In the event of repayment stress or covenant breach, lenders could invoke pledged shares, potentially leading to changes in promoter ownership levels.
Risk Level: Medium
Company Commentary
- Ayush Agrawal disclosed creation of pledge on 28,55,925 shares.
- The pledge was created for securing a new loan.
- The transaction was reported under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- CTL Trusteeship Limited is the entity in whose favour the shares have been pledged.
Official Exchange Filing: Ajanta Pharma Limited